A study used to determine "safe" levels of the rocket-fuel chemical perchlorate in drinking water is coming under increasing scrutiny.
"The vilification of threatening research as 'junk science' and the corresponding sanctification of industry-commissioned research as 'sound science' has become nothing less than standard operating procedure in some parts of corporate America," writes Clinton-era Energy Department epidemiologist David Michaels.
One of PR Watch's "usual suspects," Steven J. Milloy, managed to get himself invited to be a judge for the 2004 American Association for the Advancement of Science (AAAS) Journalism Awards: Online Category.
"It is hard to convey just how selective you have to be to dismiss the evidence for climate change," writes George Monbiot.
A National Cancer Institute study found that "workers exposed to average levels of benzene" were four times more likely to develop cancer. Benzene is a component of gasoline, so tighter regulations would have "an impact on gasoline production," said a former Mobil Oil toxicologist.
In an unprecedented move, the U.S. chemical industry is attempting to discredit two historians who have detailed the industry's efforts to hide links between their products and cancer.
Dr. Ignacio Chapela, whose research revealed contamination of native Mexican corn with genetically engineered DNA, taught his last class at University of California, Berkeley. Chapela was denied tenure at Berkeley, despite "overwhelming support from his own department and from his academic peers," GM Watch founder Jonathan Matthews writes. Chapela had also been a critic of a $25 million research deal between UC Berkeley and the Swiss biotechnology company Novartis (now Syngenta).
Last December, researchers involved with studying the use of antidepressants in children faced questions as federal regulators looked into evidence that the drugs increased suicide risks. The researchers tried "for months to gather all the test data," writes Barry Meier, but "could get only pieces of that information. Some drug companies refused to turn over data to the group, even though these researchers had helped come up with it. ...